LUCD Lucid Diagnostics Inc. Insider Trading

Director Dennis Matheis bought 245,000 shares of LUCD at $1.00 on 2026-05-20, raising holdings to 1.03M shares (+31.1%).

Dennis Matheis (Director) purchased 245,000 shares at $1.00, expanding his holdings by +31.1% to 1,033,443 shares. The stock is currently trading at $1.00, down -41.2% from its 52-week high of $1.70 and down -21.9% over the past 30 days. Matheis has a mixed track record at this ticker: of his 4 prior trades at LUCD, only 1 (the August 2025 buy) showed a positive 90-day return (+3.1%), while the other three purchases have generated losses ranging from -2.7% to -24.9% at the 90-day mark. This current purchase follows a pattern of repeated accumulation at declining prices, with his most recent prior transaction occurring one year earlier (May 20, 2025) at the same price point. The company remains unprofitable, reporting a net loss of $-13,909,000.00 in its latest quarter against quarterly revenue of $1,256,000.00.

Director Matheis Dennis bought 100,000 shares of LUCD at $1.02; stock down 30.8% in 90 days, his three prior buys at this ticker all negative.

Matheis Dennis, a director, purchased 100,000 shares (100.0K shares) at $1.02 on 2025-08-20, increasing his holdings by 17.7% to 665,443 shares (665.4K shares). The timing warrants attention: the stock has declined 30.8% over the past 90 days and is currently 33.3% below its 52-week high of $1.65. More significantly, Dennis's three prior purchases at LUCD (on 2025-05-20, 2025-05-21, and 2025-05-22) all resulted in negative 90-day returns ranging from -21.9% to -24.9%, with a 0.00% win rate over 90-day periods at this ticker. The company remains unprofitable with a net income of $-4,439,000.00 ($-4.4M) in its latest quarter, though it reported strong annual revenue growth of 79.0%. The pattern of consecutive purchases into a declining stock without measurable success over the 90-day horizon suggests this transaction should be evaluated carefully against the documented outcomes of the insider's recent trades at the same ticker.

Director Matheis Dennis purchased 350,000 shares at blended avg $1.31 over 3 days, accumulating initial 350.0K share position at LUCD.

Director Matheis Dennis executed 3 separate purchases totaling 350,000 shares for $457,606.58 across May 20–22, establishing a new director position at a blended average price of $1.31 per share. The company is currently unprofitable with a net income of $-26,908,000 over its most recent full fiscal year, though it posted strong annual revenue growth of +79.0%. At the current price of $1.33, the acquisition is marginally above his blended entry cost, and the stock remains -19.4% from its 52-week high of $1.65. This accumulation by a new director warrant scrutiny into the motivations and timing, particularly given the company's significant operating losses and the size of the position relative to the public float.